Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHMI-trans malaria transmission model study
2017-004005-40Phase 2Completed
- Sponsor
- Radboud University Medical Center
- Start
- May 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of piperaquine, sulfadoxine and pyrimethamine in Falciparum malaria (PF), sponsored by Radboud University Medical Center. Started May 2018; status: completed.
02
Drugs
piperaquinesulfadoxinepyrimethamine
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on 2017-004005-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004005-40.